Clinical Trial Coverage Act of 2022
A BILL
To amend title XXVII of the Public Health Service Act to require out-of-network coverage for qualified individuals participating in approved clinical trials, and for other purposes.
Sec. 2 Amendments relating to coverage in individual and group market and under Medicare program for qualified individuals participating in approved clinical trials
“(C) in the case of routine patient costs for items or services furnished to the individual in connection with participation in the trial by a nonparticipating provider—
“(i) shall impose the same cost-sharing requirement (expressed as a copayment amount or coinsurance rate) that would apply if such item or service was furnished by a participating provider; and
“(ii) shall pay to such nonparticipating provider the amount by which the recognized amount for such item or service exceeds the cost-sharing amount for such item or service (as determined in accordance with clause (i)); and”
“(h) Other definitions—For purposes of this section, the terms “nonparticipating provider”, “participating provider”, and “recognized amount” have the meaning given such terms in section 2799A–1(a)(3).”
“(i) all items and services”
“(ii) consultation and referral services relating to approved clinical trials furnished to qualified individuals.”
“(viii) The Patient-Centered Outcomes Research Institute.”
“(3) Routine costs of care—In defining “routine costs of care” for purposes of paragraph (1), the Secretary shall define such term in a manner that provides for coverage of consultation and referral services furnished to an individual in the course of participation in a category A clinical trial.”